Cortina Asset Management’s Neos Therapeutics, Inc NEOS Stock Holding History

Cortina Asset Management’s Portfolio NEOS Stock Details NEOS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q2	–	Sell	-617,983	Closed	-$5.13M	–	256
2018 Q1	$5.13M	Sell	617,983 -85,000	-12%	-$812K	0.25%	152
2017 Q4	$7.17M	Buy	702,983 +122,480	+21%	+$1.18M	0.32%	112
2017 Q3	$5.31M	Buy	+580,503	New	+$4.41M	0.22%	171

Other funds holding NEOS

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

JGC

J. Goldman & Co New York $3.44B AUM 33.8% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

LSC

Lyon Street Capital Sausalito, California $67M AUM

Russell Investments Group London, United Kingdom $93.1B AUM 28.26% 1-Year Est. Return

GTC

Ghost Tree Capital New York $331M AUM 70.11% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Nexthera Capital New York $120M AUM 10.01% 1-Year Est. Return

SFM

Sphera Funds Management Tel Aviv, Israel $630M AUM 108.65% 1-Year Est. Return

Cortina Asset Management's NEOS Position: Q2 2018 in Review

Cortina Asset Management sold out of Neos Therapeutics, Inc (NEOS) in Q2 2018, closing a stake of 617,983 shares — an estimated $5.13M sold.

Cortina Asset Management first reported a position in NEOS in Q3 2017 and held it in 3 quarters. The position peaked at $7.17M in Q4 2017. 73 funds tracked by Wall St. Rank hold NEOS as of Q2 2018.

Cortina Asset Management reported no remaining Neos Therapeutics, Inc position as of Q2 2018 after selling out during the quarter.
Cortina Asset Management sold 617,983 Neos Therapeutics, Inc shares in Q2 2018, an estimated $5.13M.
Cortina Asset Management first reported a position in Neos Therapeutics, Inc in Q3 2017 and held it in 3 quarters.
Cortina Asset Management's Neos Therapeutics, Inc position peaked at $7.17M in Q4 2017.
73 funds tracked by Wall St. Rank held Neos Therapeutics, Inc as of Q2 2018.

Based on Cortina Asset Management's 13F filing for Q2 2018, filed 10 Aug 2018.